Entering text into the input field will update the search result below

Oramed gets roughed up

Mar. 12, 2014 1:16 PM ETOramed Pharmaceuticals Inc. (ORMP) StockORMPBy: Douglas W. House, SA News Editor
  • Shares of Oramed Pharmaceuticals (NASDAQ:ORMP) are down 13% on average volume today as the sell-off continues from its recent parabolic up move that began on December 20.
  • Prices rocketed 360% on investors' brief enthusiasm over its insulin pill only to quickly retreat after various observers began scrutinizing the situation.
  • Oramed's market cap is $121M.
  • Six mutual funds have positions, up from two a year earlier.

Recommended For You

More Trending News

About ORMP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ORMP--
Oramed Pharmaceuticals Inc.